Compound 2242
Identifiers
- Canonical SMILES:
Clc1ccc(cc1Cl)C(=O)Nc1ccc2[nH]c(CN3CCCCC3)nc2c1
- IUPAC name:
3,4-dichloro-N-{2-[(piperidin-1-yl)methyl]-1H-1,3-benzodiazol-5-yl}benzamide
- InChi:
InChI=1S/C20H20Cl2N4O/c21-15-6-4-13(10-16(15)22)20(27)23-14-5-7-17-18(11-14)25-19(24-17)12-26-8-2-1-3-9-26/h4-7,10-11H,1-3,8-9,12H2,(H,23,27)(H,24,25)
- InChiKey:
WCGKVETXIRUCNS-UHFFFAOYSA-N
External links
![]() 145979206 |
![]() CHEMBL4280015 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MLLT1 / H3 | 5.35 | myeloid leukemia | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 402.10 g/mol | |||
HBA | 5 | |||
HBD | 2 | |||
HBA + HBD | 7 | |||
AlogP | 4.42 | |||
TPSA | 62.22 | |||
RB | 4 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1002/anie.201810617 | 71 | ENL Q03111 |
H31 P68431 |
Biochemical assay | alphascreen | pIC50 (half maximal inhibitory concentration, -log10) | 5.35 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6087 | 5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide | DB07315 | |
0.5598 | 1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE | DB07974 | |
0.5294 | 5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide | DB03288 | |
0.5226 | Glasdegib | DB11978 | |
0.5067 | Veliparib | DB07232 | |
0.5054 | Nemorexant | DB15031 | |
0.4968 | PF-03463275 | DB11993 | |
0.4917 | Dabigatran | DB14726 | |
0.4913 | CP-320626 | DB03383 | |
0.4908 | USL-311 | DB15265 | |
0.4885 | 4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide | DB06938 | |
0.4832 | METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE | DB07689 | |
0.4832 | METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE | DB07765 | |
0.4798 | Capivasertib | DB12218 | |
0.4762 | Pagoclone | DB04903 |